微信关注
China
Total item
Cart Subtotal
￥ 0.00 Stem Cells / Wnt
-
LH 846
Catalog No. A13574 -
TBB
Catalog No. A15257 -
CX-4945 sodium salt
Catalog No. A16234 CK2 抑制剂CX-4945 sodium salt是一种有效的选择性ATP竞争性小分子蛋白激酶CK2抑制剂，对重组人CK2α的Ki和IC50分别为0.38和1 nM。 了解更多 -
SR-3029
Catalog No. A16235 -
Ellagic acid
Catalog No. A10344 Ellagic acid是在多种水果和蔬菜中发现的天然酚类抗氧化剂。鞣花酸的抗增殖和抗氧化特性Ellagic acid促使人们对食用鞣花酸的潜在健康益处进行了初步研究。 了解更多 -
A-3 Hydrochloride
Catalog No. A13584 PKA, PKG, Casein Kinase I and II 抑制剂A-3 Hydrochloride是PKA（cAMP依赖性蛋白激酶，Ki =4.3μM）和cGMP依赖性蛋白激酶，Ki =3.8μM，PKC（蛋白激酶C，Ki =47μM），酪蛋白激酶I和II的抑制剂， 和MLCK（肌球蛋白轻链激酶）（Ki =7.4μM）。 了解更多 -
TMCB
Catalog No. A13977 -
LDE225 Diphosphate
Catalog No. A12774 Smoothened 抑制剂LDE225 Diphosphate 是一种具有潜在抗肿瘤活性的口服生物利用小分子平滑（Smo）拮抗剂。抑制Hedgehog (Hh)信号通路，无细胞试验中IC50分别为1.3 nM (小鼠)和2.5 nM(人)。 了解更多 -
PF-5274857
Catalog No. A12775 Smoothened 抑制剂PF-5274857是一种新型Smo拮抗剂，它以4.6±1.1 nmol/L的K（i）特异性结合Smo，并以2.7±1.4 nmol/L的IC（50）完全阻断下游基因Gli1的转录活性。在细胞中。 了解更多 -
BMS-833923 (XL-139)
Catalog No. A13204 Smoothened 抑制剂BMS-833923 (XL-139)是一种生物可利用的小分子SMO(平滑)抑制剂，具有潜在的抗肿瘤活性。 了解更多 -
Glasdegib (PF-04449913)
Catalog No. A13881 -
SAG
Catalog No. A13627 -
Jervine
Catalog No. A16221 -
CHIR-98014
Catalog No. A11085 -
TWS119
Catalog No. A11223 -
Tideglusib
Catalog No. A11592 GSK-3 抑制剂Tideglusib是一种不可逆的，非ATP竞争性的GSK-3β抑制剂，无细胞试验中IC50为60 nM。用于治疗阿尔茨海默氏病和进行性核上性麻痹。 了解更多 -
AZD2858
Catalog No. A13060 -
AR-A 014418
Catalog No. A13728 GSK-3 抑制剂AR-A 014418是一种选择性糖原合酶激酶3 (GSK-3) 抑制剂 (IC50 = 104 nM)。对GSK-3的特异性超过cdk2和cdk5（IC50值> 100μM）以及26种其他激酶。抑制β-淀粉样蛋白介导的海马片神经变性。 了解更多 -
1-Azakenpaullone
Catalog No. A14303 GSK-3β 抑制剂1-Azakenpaullone是一种有效的选择性GSK-3β抑制剂，IC50为18 nM，选择性比CDK1/cyclin B和CDK5/p25高100倍。 了解更多 -
IM-12
Catalog No. A14196 -
Bikinin
Catalog No. A15526 -
BIO-acetoxime
Catalog No. A15555 GSK-3 抑制剂BIO-acetoxime是一种有效的双重GSK3α/β抑制剂，IC50为10 nM，选择性比CDK5/p25，CDK2/cyclin A和 CDK1/cyclin B高240倍以上。 了解更多 -
Indirubin-3-monoxime
Catalog No. A16280 GSK-3β 抑制剂Indirubin-3'-monoxime是一种功能强大的GSK-3β抑制剂，IC50为22nM，也抑制CDK1/5（IC50 = 180/100 nM）。 了解更多 -
-
最新产品
BIO
Catalog No. A17129 -
-
VP3.15
Catalog No. A18538 dual PDE7/GSK-3 inhibitorVP3.15 is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS). 了解更多 -
CHIR-99021 monohydrochloride
Catalog No. A21430 GSK-3α/β inhibitorCHIR-99021 monohydrochloride (CT99021 monohydrochloride) is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM; > 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases. 了解更多 -
CHIR-99021 trihydrochloride
Catalog No. A21436 GSK-3α/β inhibitorCHIR-99021 trihydrochloride (CT99021 trihydrochloride) is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM. 了解更多 -
VP3.15 dihydrobromide
Catalog No. A21789 PDE7/GSK3 inhibitorVP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. 了解更多 -
GSK-3 inhibitor 1
Catalog No. A21803 -
Verteporfin
Catalog No. A12658 YAP 抑制剂Verteporfin是抑制TEAD-YAP缔合和YAP诱导的肝过度生长的小分子。它也是一种有效的第二代光敏剂，衍生自卟啉。 了解更多 -
BMS-708163 (Avagacestat)
Catalog No. A10157 Gamma-secretase 抑制剂BMS-708163 (Avagacestat)是口服生物有效的，选择性的γ-分泌酶抑制剂，作用于Aβ40和Aβ42时，IC50分别为0.3 nM和0.27 nM。 了解更多 -
DAPT (GSI-IX)
Catalog No. A10288 Gamma secretase 抑制剂DAPT (GSI-IX)是一种γ-分泌酶抑制剂，可导致人原代神经元培养物中Aβ40和Aβ42水平降低，总Aβ和Aβ42的IC50值分别为115和200 nM。 了解更多
FILTER BY:
购物选项
- 分类
-
- Hedgehog (16)
- Wnt (28)
- β-catenin (18)
- Casein Kinase (14)
- Smoothened (7)
- GSK-3 (25)
- Hippo (2)
- γ-Secretase (34)
- 作用机制
-
- Inhibitor (抑制剂) (102)
- Agonist (激动剂) (4)
- Antagonist (拮抗剂) (6)
- Activator (激活剂) (3)
- Modulator (调节剂) (10)
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
ADOOQ 产品质量保证
We promise all products to perform as described.